U.S. market Closed. Opens in 16 hours 40 minutes

LUMO | Lumos Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
Revenue2.05M1.52M230.00K168.00K936.00K1.21M28.71M35.77M68.50M172.59M1.09M1.69M1.87M2.08M934.00K633.00K
Cost of Revenue44.00K49.00KN/AN/A37.00K-11.27MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit2.01M1.47M230.00K168.00K899.00K12.47MN/AN/AN/A172.59M1.09M1.69M1.87M2.08M934.00K633.00K
Operating Expenses38.62M33.56M31.58M26.47M46.07M63.64M101.59M126.53M102.10M55.02M32.23M24.95M19.93M18.74M10.75M10.05M
Selling, General & Admin16.52M15.71M15.33M17.27M23.86M29.22M30.63M32.73M30.69M19.33M9.52M7.11M5.68M6.07M5.19M4.60M
Research & Development22.10M17.86M16.25M9.21M22.20M45.69M69.27M82.20M71.41M35.69M22.71M17.84M14.26M12.67M5.56M5.45M
Other Operating Expenses683.00K91.00K269.00K6.47M-19.00K-102.00K1.70M11.60MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-36.61M-32.04M-31.35M-26.30M-45.13M-62.44M-72.88M-90.76M-33.60M117.57M-31.14M-23.26M-18.06M-16.66M-9.82M-9.41M
Other Expenses / Income2.55M965.00K281.00K6.67M2.16M-102.00K371.00K247.00K-41.00K60.00K91.00K-62.00K-25.00K71.00K19.00K42.00K
Before Tax Income-34.06M-31.07M-31.07M-19.64M-42.98M-60.56M-72.51M-90.51M-33.64M117.63M-31.05M-23.32M-18.09MN/AN/AN/A
Income Tax Expenses-29.00K-13.00K-636.00K-13.97M12.00K-6.97M-559.00K-5.36M6.74M14.78M130.00KN/AN/AN/AN/AN/A
Net Income-34.03M-31.06M-30.43M-5.66M-42.99M-53.59M-71.95M-85.16M-40.38M102.86M-31.18M-23.32M-18.09M-16.21M-9.44M-9.16M
Interest ExpensesN/A874.00KN/AN/A50.00K52.00K119.00K22.00K105.00K26.00K33.00K38.00K42.00K47.00K9.00K2.00K
Basic Shares Outstanding8.15M8.37M8.33M6.78M144.71K4.13M3.48M3.22M3.18M27.84M25.28M20.78M6.06M1.57M1.60M1.60M
Diluted Shares Outstanding8.15M8.37M8.33M6.78M144.71K4.13M3.48M3.22M3.18M31.03M25.28M20.78M6.06M1.57M1.60M1.60M
EBITDA-36.57M-32.04M-31.35M-26.30M-42.93M-60.51M-70.98M-88.41M-31.95M118.76M-30.13M-22.50M-17.36M-15.51M-9.13M-8.87M
EBITDA Margin-1,783.03%-2,103.74%-13,629.13%-15,656.55%-4,586.22%-5,017.50%-247.24%-247.16%-46.64%68.81%-2,756.27%-1,333.43%-927.24%-746.08%-977.52%-1,400.63%
EBIT-34.06M-30.20M-31.07M-19.64M-42.93M-60.51M-72.39M-90.49M-33.54M117.66M-31.02M-23.28M-18.05M-16.17M-9.43M-9.16M
EBIT Margin-1,660.80%-1,982.99%-13,506.96%-11,688.10%-4,586.22%-5,017.50%-252.14%-252.99%-48.96%68.17%-2,837.79%-1,380.14%-963.94%-777.59%-1,009.96%-1,447.08%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙